Transgenic and Gene Targeting Core
转基因和基因靶向核心
基本信息
- 批准号:7647669
- 负责人:
- 金额:$ 19.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Flanking Region5&apos Flanking RegionAgar Gel ElectrophoresisAllelesAmpicillinAnimal ModelAnimalsAortaApolipoprotein EAreaAscaridilAtherosclerosisBackBackcrossingsBacterial Artificial ChromosomesBoxingBreedingBudgetsBuffersC57BL/6 MouseCD31 AntigensCandidate Disease GeneCell Culture TechniquesCell LineCellsChimeric ProteinsChloroformClone CellsCloningColorCommunitiesComplementary DNACongenic MiceCongenic StrainConsultationsCore FacilityCritiquesDNADNA SequenceDNA analysisDNA purificationDUSP1 geneDataData SetDatabasesDevelopmentDigestionDiseaseDocumentationDominant-Negative MutationES Cell LineElectroporationElementsEmbryoEmbryo TransferEndothelial CellsEngineeringEnhancersEnsureEnterochromaffin CellsEscherichia coliEthanolExcisionExonsExperimental DesignsFigs - dietaryFluorescenceFosteringFreezingFundingFutureGelGene ExpressionGene ProteinsGene TargetingGene-ModifiedGenerationsGenesGeneticGenetic RecombinationGenetically Modified AnimalsGenomeGenomicsGenotypeGerm CellsGlycineGrantHealthHourHumanHuman ResourcesIndividualInjection of therapeutic agentInner Cell MassJointsKnock-outKnockout MiceLipidsLipoproteinsLocationMacrophage Colony-Stimulating FactorMaintenanceMediatingMessenger RNAMetabolismMethodsMicroinjectionsMicrosatellite RepeatsModelingModificationMolecular BiologyMothersMouse StrainsMusMutant Strains MiceMutateMutationNatureNeomycinNeomycin resistance geneNorthern BlottingNucleic AcidsOccupationsOperative Surgical ProceduresPatternPersonsPhenolsPlasmid Cloning VectorPlasmidsPolymerase Chain ReactionPostdoctoral FellowPrecipitationPrincipal InvestigatorProceduresProcessProductionProlineProteinsProto-OncogenesProtocols documentationPublicationsPublished CommentReactionReplication OriginReporterReporter GenesResearchResearch PersonnelReverse Transcriptase Polymerase Chain ReactionSamplingScanningScreening procedureSepharoseServicesSimplexvirusSiteSouthern BlottingSpecific qualifier valueSpeedStem cellsStreamStructural GenesSusceptibility GeneSystemic Lupus ErythematosusTK GeneTechniquesTechnologyTemperatureTerminator CodonTestingTetanus Helper PeptideTetracycline ResistanceThymidine KinaseTissuesTransfectionTransgenesTransgenic MiceTransgenic OrganismsUterusVWF geneVascular Endothelial Growth Factor Receptor-2Western BlottingWild Type MouseWorkYanganalogantibiotic G 418baseblastocystcadherin 5cell typecongeniccostcourtdata managementdensitydesigndesign and constructioneggembryonic stem cellexperiencefialuridinegenome wide association studyheme oxygenase-1hindbrainhomologous recombinationinterestmacrophagemalemouse modelmutantnovelnull mutationprogramspromoterprotein expressionreceptorresearch studyresponserestriction enzymestemsuccesstransmission processvector
项目摘要
Core C is a continuing core for Trangenic and Gene Targeting of Mice. In the next grant cycle Core C will
assist Project 1 in constructing endothelial specific knockouts of SCAP and STATS on the LDL receptor null
background.Core C will assist Projects 1 arid 2 in constructing HO-1 conditional and endothelial specific,
knockout of HO-1 on the apoE null background. Core C will assist Project 3 in construction of a MGP-P64Q
mutant mouse through gene targeting and will assist Project 3 in the generation of Abcc6-Wnt-promoterbeta-
gal reporter double transgenic mice. Core C will provide consultation on breeding and colony
management of transgenic mouse models to Project 4. Core C will assist Project 5 construction of,
transgenci mice for testing atherosclerosis-related candidate genes. Core C will assist Project 6 with the
construction of transgenic mice expressing dominant negatie NR4A receptor in macrophages. Core C will ,
also provide assistance to Core A in the characterization of primary cultues of mouse aortic endothelial cells
by performing qPCR and Western blot analysis.These functions of Core C are essential to ensuring the
efficient and cost-effective completion of the specific aims of all of the component Projects.
核心C是小鼠跨齿和基因靶向的持续核心。在下一个赠款周期中,核心C将
协助项目1构建LDL受体NULL上的SCAP和统计数据的内皮特异性敲除
背景Corcor C将协助项目1 ARID 2来构建HO-1条件和内皮特异性,
在apoe null背景上敲除ho-1。 Core C将协助项目3构建MGP-P64Q
突变小鼠通过基因靶向,并将协助项目3的生成
GAL报告基因双转基因小鼠。 C核心将提供有关育种和殖民地的咨询
对项目4的转基因鼠标模型的管理。CoreC将协助项目5的构建,
用于测试与动脉粥样硬化相关的候选基因的基因小鼠。核心C将协助项目6
在巨噬细胞中表达主导性NR4A受体的转基因小鼠的结构。核心将
还为核心A提供了辅助,以表征小鼠主动脉内皮细胞的原发性培养基
通过执行QPCR和Western印迹分析。这些核心C的功能对于确保确保
所有组件项目的具体目标有效且具有成本效益的完成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DIANA Mouhan SHIH其他文献
DIANA Mouhan SHIH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DIANA Mouhan SHIH', 18)}}的其他基金
相似海外基金
Human genetic supplementation without donor DNA or a DNA break
无需供体 DNA 或 DNA 断裂的人类基因补充
- 批准号:
10532612 - 财政年份:2022
- 资助金额:
$ 19.8万 - 项目类别:
Human genetic supplementation without donor DNA or a DNA break
无需供体 DNA 或 DNA 断裂的人类基因补充
- 批准号:
10471949 - 财政年份:2020
- 资助金额:
$ 19.8万 - 项目类别:
Human genetic supplementation without donor DNA or a DNA break
无需供体 DNA 或 DNA 断裂的人类基因补充
- 批准号:
10687195 - 财政年份:2020
- 资助金额:
$ 19.8万 - 项目类别:
Human genetic supplementation without donor DNA or a DNA break
无需供体 DNA 或 DNA 断裂的人类基因补充
- 批准号:
10912151 - 财政年份:2020
- 资助金额:
$ 19.8万 - 项目类别:
Human genetic supplementation without donor DNA or a DNA break
无需供体 DNA 或 DNA 断裂的人类基因补充
- 批准号:
10259688 - 财政年份:2020
- 资助金额:
$ 19.8万 - 项目类别: